Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1538260104
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-5234
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
352 services
Medicare patients, 2024
95
Average age 72
Drug cost, 2024
$676K
354 prescriptions
Company payments, 2025
$18K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sakti Chakrabarti was code 99214 (office e&m - established), 202 times for 62 patients. In total Sakti Chakrabarti billed 352 services in 12 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 202 | 62 | $66.24 | $13K |
| 99215 Office E&M - Established | Facility | 46 | 28 | $99.79 | $4,590 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 13 | $87.43 | $2,885 |
| 99213 Office E&M - Established | Facility | 30 | 20 | $48.37 | $1,451 |
| 99205 Office E&M - New | Facility | 21 | 21 | $138.07 | $2,899 |
By year: 2022 $38K for 469 services; 2023 $28K for 354 services; 2024 $27K for 352 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sakti Chakrabarti prescribed most often to Medicare patients was Prochlorperazine Maleate, with 55 prescriptions and refills. In total Sakti Chakrabarti wrote 354 Medicare prescriptions that cost $676K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 55 | 55 | 29 | $622 |
| Ondansetron Hcl Generic | 30 | 34 | 21 | $505 |
| Fruzaqla Fruquintinib | 26 | 26 | Under 11 | $599K |
| Ondansetron Odt Ondansetron | 24 | 24 | 12 | $354 |
| Loperamide Loperamide Hcl | 20 | 21 | 17 | $536 |
| Potassium Chloride Generic | 19 | 26 | Under 11 | $360 |
| Imatinib Mesylate Generic | 17 | 17 | Under 11 | $6,037 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 16 | 16 | 12 | $162 |
| Olanzapine Generic | 15 | 23 | Under 11 | $294 |
Brand drugs: 50 claims; generic drugs: 304 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sakti Chakrabarti $18K ($18K in general payments such as food, travel and fees) from 8 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $17K |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $495 |
| Incyte Corporation INCY | 1 | $123 |
| Array Biopharma Inc PFE | 1 | $76.33 |
| Janssen Research & Development, LLC JNJ | 1 | $37.53 |
| Pfizer Inc. PFE | 1 | $20.48 |
| Genentech USA, Inc. ROG.SW | 1 | $18.95 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $16.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.